Clincosm LogoSign in Get a demo

Obesity

Showing NaN - NaN of 33
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity Trial in Worldwide (Cagrilintide, Semaglutide, Placebo)

Not yet recruiting
  • Obesity
  • Birmingham, Alabama
  • +253 more
Jan 24, 2023

Obesity Trial in Lexington, Chapel Hill (Enhanced Go NAPSACC, Basic Go NAPSACC)

Active, not recruiting
  • Obesity
  • Enhanced Go NAPSACC
  • Basic Go NAPSACC
  • Lexington, Kentucky
  • +1 more
Oct 25, 2022

Knee Osteoarthritis, Obesity, Depression Trial in Lexington (GetHealthy-OA, Health Enhancement Program)

Recruiting
  • Knee Osteoarthritis
  • +2 more
  • GetHealthy-OA
  • Health Enhancement Program
  • Lexington, Kentucky
  • +1 more
Sep 12, 2022

Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Obesity
  • Fairhope, Alabama
  • +97 more
Jun 15, 2022

Obesity, Weight Loss, Eating Behavior Trial in Lexington (exericse)

Active, not recruiting
  • Obesity
  • +2 more
  • exericse
  • Lexington, Kentucky
    University of Kentucky- Nutrition Assessment Lab
Feb 8, 2022

Obesity Trial in Lexington (Milk Thistle (MT), Lactobacillus Gasseri (LAC), Exercise (EX))

Recruiting
  • Obesity
  • Milk Thistle (MT)
  • +3 more
  • Lexington, Kentucky
    University of Kentucky- Nutrition Assessment Lab
Jan 11, 2022

Pre-diabetes, Obesity Trial in Lexington (Mirabegron 50 MG, Tadalafil 10 MG, Placebo)

Recruiting
  • Pre-diabetes
  • Obesity
  • Mirabegron 50 MG
  • +2 more
  • Lexington, Kentucky
    University of Kentucky
Dec 13, 2021

Obesity, Overweight Trial in Worldwide (Semaglutide 1.0 mg, Semaglutide 2.4 mg, Placebo I (Semaglutide))

Completed
Has Results
  • Obesity
  • Overweight
  • Semaglutide 1.0 mg
  • +3 more
  • Buena Park, California
  • +146 more
Nov 8, 2021

Dietary Sources of Lysophospholipids

Terminated
  • Obesity
  • +2 more
    • Lexington, Kentucky
      University of Kentucky Dept of Cardiology
    Jul 20, 2021

    Obesity, Exercise Reinforcement Trial in Lexington (Exercise)

    Completed
    • Obesity
    • Exercise Reinforcement
    • Exercise
    • Lexington, Kentucky
      Funkhouser Building
    Dec 11, 2019

    Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue Trial in Korea, Republic of, United States

    Unknown status
    Has Results
    • Endometrial Clear Cell Adenocarcinoma
    • +6 more
    • 3-Dimensional Conformal Radiation Therapy
    • +7 more
    • Birmingham, Alabama
    • +539 more
    Mar 8, 2019

    Cardiovascular Diseases, Heart Diseases, Metabolic Syndrome X Trial in Greensboro, Lexington, Winston-Salem (Exercise, Weight

    Completed
    • Cardiovascular Diseases
    • +3 more
    • Exercise
    • +2 more
    • Greensboro, North Carolina
    • +2 more
    Aug 13, 2018

    Obesity, Critical Illness Trial in Lexington (Levofloxacin 750 mg IV)

    Completed
    Has Results
    • Obesity
    • Critical Illness
    • Levofloxacin 750 mg IV
    • Lexington, Kentucky
      University of Kentucky
    May 7, 2018

    Obesity Trial in United States (S-2367 Placebo, S-2367 1600 mg q.d. 54 Weeks, S-2367 1600 mg q.d. 60 weeks)

    Completed
    • Obesity
    • S-2367 Placebo
    • +4 more
    • Birmingham, Alabama
    • +39 more
    May 9, 2018

    Obesity Trial in United States (S-2367 (velneperit))

    Completed
    • Obesity
    • S-2367 (velneperit)
    • Birmingham, Alabama
    • +72 more
    Apr 26, 2018

    Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )

    Completed
    Has Results
    • Metabolism and Nutrition Disorder
    • Obesity
    • Vestavia Hills, Alabama
    • +160 more
    Dec 6, 2017

    Cancer, Obesity Trial in United States (Walk by Faith)

    Completed
    • Cancer
    • Obesity
    • Walk by Faith
    • Lexington, Kentucky
    • +4 more
    Jun 15, 2017

    Obesity, Hypertension, Hyperlipidemia Trial in Lexington (Self-care CVD risk reduction, Referral to primary care provider for

    Completed
    • Obesity
    • +3 more
    • Self-care CVD risk reduction
    • Referral to primary care provider for CVD risk management
    • Lexington, Kentucky
      University of Kentucky
    Mar 7, 2017

    Mood and Behavior Changes Among Overweight Adolescent Females

    Withdrawn
    • Obesity
    • Depression
    • Dietary and physical activity modifications
    • Lexington, Kentucky
      University of Kentucky
    Nov 7, 2016

    Obesity Trial in United States (Canagliflozin, Phentermine, Matching Placebo to Canagliflozin)

    Completed
    Has Results
    • Obesity
    • Phoenix, Arizona
    • +16 more
    Aug 10, 2016

    Overweight, Obesity Trial in United States (pramlintide acetate)

    Completed
    • Overweight
    • Obesity
    • pramlintide acetate
    • Chula Vista, California
    • +9 more
    Jun 10, 2015

    Obesity, Overweight, Diabetes, Type 2 Trial in United States (Naltrexone SR 32 mg/bupropion SR 360 mg/ day, Placebo, Ancillary

    Completed
    Has Results
    • Obesity
    • +2 more
    • Naltrexone SR 32 mg/bupropion SR 360 mg/ day
    • +2 more
    • Fairhope, Alabama
    • +52 more
    Nov 18, 2014

    Obesity, Overweight Trial in United States (Naltrexone SR 16 mg/Bupropion SR 360 mg /day, Naltrexone SR 32 mg/Bupropion SR 360

    Completed
    Has Results
    • Obesity
    • Overweight
    • Naltrexone SR 16 mg/Bupropion SR 360 mg /day
    • +3 more
    • Birmingham, Alabama
    • +33 more
    Nov 18, 2014

    Feeding Trial in the Obese Critical Care Population

    Completed
    • Critical Illness
    • Obesity
    • enteral formula
    • Lexington, Kentucky
    • +1 more
    Jan 29, 2014

    Obesity Trial in Puerto Rico, United States (Canagliflozin (JNJ-28431754), Placebo)

    Completed
    Has Results
    • Obesity
    • Canagliflozin (JNJ-28431754)
    • Placebo
    • Hot Springs, Arkansas
    • +35 more
    Apr 1, 2013